CLINICAL_TRIALS
trial_result
· 2015-04-16
Clinical Trial Update: Caffeine for Motor Manifestations of Parkinson's Disease [Phase 2]
Summary
A Phase 2 clinical trial evaluating caffeine for motor manifestations of Parkinson's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ron Postuma | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED